SILVERBACK THERAPEUTICS INC's ticker is SBTX and the CUSIP is 82835W108. A total of 75 filers reported holding SILVERBACK THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,941,746 | -84.2% | 1,307,340 | -72.0% | 0.00% | -100.0% |
| Q2 2023 | $31,254,014 | -52.8% | 4,664,778 | -54.2% | 0.00% | 0.0% |
| Q1 2023 | $66,249,052 | +44.6% | 10,176,506 | +89.5% | 0.00% | -40.0% |
| Q4 2022 | $45,800,659 | +82.1% | 5,369,362 | +12.7% | 0.01% | +66.7% |
| Q3 2022 | $25,152,000 | +59.5% | 4,763,549 | +28.1% | 0.00% | +50.0% |
| Q2 2022 | $15,766,000 | +18.4% | 3,718,452 | -2.0% | 0.00% | +100.0% |
| Q1 2022 | $13,314,000 | -46.7% | 3,793,172 | +1.1% | 0.00% | -50.0% |
| Q4 2021 | $25,000,000 | -41.6% | 3,753,737 | -12.5% | 0.00% | -33.3% |
| Q3 2021 | $42,800,000 | -70.4% | 4,288,549 | -8.5% | 0.00% | -72.7% |
| Q2 2021 | $144,811,000 | -30.7% | 4,687,968 | -2.9% | 0.01% | -38.9% |
| Q1 2021 | $208,816,000 | +34.0% | 4,825,559 | +40.2% | 0.02% | +28.6% |
| Q4 2020 | $155,810,000 | – | 3,441,304 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SR ONE CAPITAL MANAGEMENT, LP | 4,012,903 | $26,123,999 | 9.73% |
| Nextech Invest Ltd. | 1,910,029 | $12,434,289 | 5.19% |
| K2 PRINCIPAL FUND, L.P. | 2,686,490 | $17,489,051 | 2.41% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 11,077,927 | $72,117,305 | 1.61% |
| Orbimed Advisors | 8,740,887 | $56,903,174 | 1.12% |
| SECTORAL ASSET MANAGEMENT INC | 793,587 | $5,166,251 | 0.99% |
| Tejara Capital Ltd | 207,555 | $1,351,183 | 0.69% |
| Rubric Capital Management LP | 3,480,712 | $22,659,435 | 0.59% |
| Resolute Capital Asset Partners LLC | 120,000 | $781 | 0.57% |
| RA Capital Management | 3,009,678 | $19,593,004 | 0.44% |